Airton Tetelbom Stein

Airton Tetelbom Stein

Auto-generated profile, based on publicly available information

Airton Tetelbom Stein

Universidade Federal de Ciências da Saúde de Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Cadernos de Saude Publica
Verified
Journal Article
Open access
PDF file
DGDaniel Maffasioli Gonçalves
Daniel Maffasioli Gonçalves
ASAirton Tetelbon Stein
Airton Tetelbon Stein
FKFlavio Kapczinski
Flavio Kapczinski
O SRQ (Self-Reporting Questionnaire) é um instrumento de rastreamento psiquiátrico originalmente composto por 30 itens. A versão brasileira do SRQ-20 (versão com as 20 questões para rastreamento de transtornos mentais não-psicóticos) foi validada no início da década de 1980. O objetivo deste estudo foi validar a versão brasileira do SRQ-20 e dos cinco itens de rastreamento de transtorno por uso de álcool oriundos do SRQ-30, comparando com entrevista psiquiátrica usando SCID-IV-TR (Structured Clinical Interview for DSM-IV-TR) como padrão-ouro. O estudo foi conduzido em Santa Cruz do Sul, Rio Grande do Sul, Brasil, com 485 indivíduos (54,8% mulheres, idade média 40,04). Os 5 itens de rastreamento de transtornos por uso de álcool mostraram sensibilidade baixa (66%). O SRQ-20 apresentou como ponto de corte ideal 7/8, com sensibilidade de 86,33% e especificidade de 89,31%. O poder discriminante para diagnóstico psiquiátrico do SRQ-20 foi 0,91. O coeficiente Cronbach alfa foi 0,86.

1 January 2010 in World Allergy Organization Journal
Verified
Journal Article
Open access
AFAlessandro Fiocchi
Alessandro Fiocchi
JBJan Brozek
Jan Brozek
HSHolger Schünemann
Holger Schünemann
SBSami L Bahna
Sami L Bahna
ABAndrea von Berg
Andrea von Berg
SVStefan Vieths
Stefan Vieths
Providing a high-quality forum for the global dissemination of research in allergy, asthma and clinical immunology, the World Allergy Organization Journal is the official publication of the World Allergy Organization. As an open access platform publishing cutting-edge basic, clinical and translational research, the journal offers fast and rigorous peer review led by an international Editorial Board, and is dedicated to expanding our understanding of the pathogenesis, diagnosis and treatment of allergic diseases.

1 February 2020 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
JPJennifer Petkovic
Jennifer Petkovic
ARAlison Riddle
Alison Riddle
EAElie A. Akl
Elie A. Akl
JKJoanne Khabsa
Joanne Khabsa
LLLyubov Lytvyn
Lyubov Lytvyn
PTPeter Tugwell
Peter Tugwell
Background: Stakeholder engagement has become widely accepted as a necessary component of guideline development and implementation. While frameworks for developing guidelines express the need for those potentially affected by guideline recommendations to be involved in their development, there is a lack of consensus on how this should be done in practice. Further, there is a lack of guidance on how to equitably and meaningfully engage multiple stakeholders. We aim to develop guidance for the meaningful and equitable engagement of multiple stakeholders in guideline development and implementation. Methods: This will be a multi-stage project. The first stage is to conduct a series of four systematic reviews. These will (1) describe existing guidance and methods for stakeholder engagement in guideline development and implementation, (2) characterize barriers and facilitators to stakeholder engagement in guideline development and implementation, (3) explore the impact of stakeholder engagement on guideline development and implementation, and (4) identify issues related to conflicts of interest when engaging multiple stakeholders in guideline development and implementation. Discussion: We will collaborate with our multiple and diverse stakeholders to develop guidance for multi-stakeholder engagement in guideline development and implementation. We will use the results of the systematic reviews to develop a candidate list of draft guidance recommendations and will seek broad feedback on the draft guidance via an online survey of guideline developers and external stakeholders. An invited group of representatives from all stakeholder groups will discuss the results of the survey at a consensus meeting which will inform the development of the final guidance papers. Our overall goal is to improve the development of guidelines through meaningful and equitable multi-stakeholder engagement, and subsequently to improve health outcomes and reduce inequities in health.

1 February 2013 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
LPLeila Mmb Pereira
Leila Mmb Pereira
CMCelina Maria Turchi Martelli
Celina Maria Turchi Martelli
RMRegina Célia Moreira
Regina Célia Moreira
EMEdgar Merchan-Hamman
Edgar Merchan-Hamman
ASAirton T Stein
Airton T Stein
RXRicardo Aa Ximenes
Ricardo Aa Ximenes
Background: Hepatitis C chronic liver disease is a major cause of liver transplant in developed countries. This article reports the first nationwide population-based survey conducted to estimate the seroprevalence of HCV antibodies and associated risk factors in the urban population of Brazil. Methods: The cross sectional study was conducted in all Brazilian macro-regions from 2005 to 2009, as a stratified multistage cluster sample of 19,503 inhabitants aged between 10 and 69 years, representing individuals living in all 26 State capitals and the Federal District. Hepatitis C antibodies were detected by a third-generation enzyme immunoassay. Seropositive individuals were retested by Polymerase Chain Reaction and genotyped. Adjusted prevalence was estimated by macro-regions. Potential risk factors associated with HCV infection were assessed by calculating the crude and adjusted odds ratios, 95% confidence intervals (95% CI) and p values. Population attributable risk was estimated for multiple factors using a case–control approach. Results: The overall weighted prevalence of hepatitis C antibodies was 1.38% (95% CI: 1.12%–1.64%). Prevalence of infection increased in older groups but was similar for both sexes. The multivariate model showed the following to be predictors of HCV infection: age, injected drug use (OR = 6.65), sniffed drug use (OR = 2.59), hospitalization (OR = 1.90), groups socially deprived by the lack of sewage disposal (OR = 2.53), and injection with glass syringe (OR = 1.52, with a borderline p value). The genotypes 1 (subtypes 1a, 1b), 2b and 3a were identified. The estimated population attributable risk for the ensemble of risk factors was 40%. Approximately 1.3 million individuals would be expected to be anti-HCV-positive in the country. Conclusions: The large estimated absolute numbers of infected individuals reveals the burden of the disease in the near future, giving rise to costs for the health care system and society at large. The known risk factors explain less than 50% of the infected cases, limiting the prevention strategies. Our findings regarding risk behaviors associated with HCV infection showed that there is still room for improving strategies for reducing transmission among drug users and nosocomial infection, as well as a need for specific prevention and control strategies targeting individuals living in poverty.

10 June 2011 in Implementation Science
Verified
Journal Article
Open access
PDF file
JHJonathan Hsu
Jonathan Hsu
JBJan L Brożek
Jan L Brożek
LTLuigi Terracciano
Luigi Terracciano
JKJulia Kreis
Julia Kreis
ECEnrico Compalati
Enrico Compalati
HSHolger J Schünemann
Holger J Schünemann
Background: Accurate diagnosis is a fundamental aspect of appropriate healthcare. However, clinicians need guidance when implementing diagnostic tests given the number of tests available and resource constraints in healthcare. Practitioners of health often feel compelled to implement recommendations in guidelines, including recommendations about the use of diagnostic tests. However, the understanding about diagnostic tests by guideline panels and the methodology for developing recommendations is far from completely explored. Therefore, we evaluated the factors that guideline developers and users need to consider for the development of implementable recommendations about diagnostic tests. Methods: Using a critical analysis of the process, we present the results of a case study using the Grading of Recommendations Applicability, Development and Evaluation (GRADE) approach to develop a clinical practice guideline for the diagnosis of Cow Milk Allergy with the World Allergy Organization. Results: To ensure that guideline panels can develop informed recommendations about diagnostic tests, it appears that more emphasis needs to be placed on group processes, including question formulation, defining patient-important outcomes for diagnostic tests, and summarizing evidence. Explicit consideration of concepts of diagnosis from evidence-based medicine, such as pre-test probability and treatment threshold, is required to facilitate the work of a guideline panel and to formulate implementable recommendations. Discussion: This case study provides useful guidance for guideline developers and clinicians about what they ought to demand from clinical practice guidelines to facilitate implementation and strengthen confidence in recommendations about diagnostic tests. Applying a structured framework like the GRADE approach with its requirement for transparency in the description of the evidence and factors that influence recommendations facilitates laying out the process and decision factors that are required for the development, interpretation, and implementation of recommendations about diagnostic tests.

15 April 2009 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Open access
PDF file
LMLídia Rf Medeiros
Lídia Rf Medeiros
DRDaniela D Rosa
Daniela D Rosa
MBMary C Bozzetti
Mary C Bozzetti
JFJandyra Mg Fachel
Jandyra Mg Fachel
SFSusan Furness
Susan Furness
ASAirton T Stein
Airton T Stein
Over the last 10 years laparoscopy and minilaparotomy have become increasingly common approaches for the surgical removal of benign ovarian tumours. However, in the event that a tumour is found to be malignant, laparotomy is the appropriate procedure. Careful preoperative assessment including transvaginal ultrasound with morphological scoring, colour doppler assessment of vascular quality, and serum cancer antigen 125 (CA 125) level is desirable. To determine the benefits, harms, and cost of laparoscopy or minilaparotomy compared with laparotomy in women with benign ovarian tumours. We searched electronic databases, trial registers, and reference lists of published trial reports. Reference lists from trials and review articles were searched. All randomised controlled trials comparing either laparoscopy or minilaparotomy with laparotomy for benign ovarian tumours. Eight review authors independently assessed the eligibility and quality of each study and extracted the data. The results of nine randomised controlled trials (N = 482 women) showed that laparoscopic surgery was associated with fewer adverse events of surgery (surgical injury or postoperative complications including fever or infection) (OR 0.3, 95% CI 0.2 to 0.5), less postoperative pain (VAS score WMD -2.4, 95% CI -2.7 to -2.0), greater likelihood of being pain free after two days (OR 7.42, 95% CI 4.86 to 11.33), and fewer days in hospital (WMD -2.88, 95% CI -3.1 to -2.7) than with laparotomy.In one study that reported costs, laparoscopy was associated with a significant reduction in costs compared to laparotomy (WMD - USD 1045, 95% CI -1348 to -742) in 1993. Very high levels of heterogeneity made it inappropriate to pool data on duration of surgery.Three RCTs compared laparoscopy versus minilaparotomy and found that laparoscopy was associated with reduced odds of any adverse event (surgical injury or postoperative complications) (OR 0.10, 95% CI 0 to 0.8) and lower VAS scores for pain (WMD -1.0, 95% CI -1.6 to -0.45). Duration of hospital stay ranged between 1 and 2.2 days, with substantial heterogeneity. In women undergoing surgery for benign ovarian tumours, laparoscopy was associated with a reduction in fever, urinary tract infection, postoperative complications, postoperative pain, number of days in hospital, and total cost. These findings should be interpreted with caution since only a small number of studies were identified. These included a total of only 769 women and not all of the important outcomes were reported in each study.